In pancreatic cancer, Cao et al. found that the P4HA1-HIF1α loop acted as a crucial regulator in glycolysis and oncogenesis and might serve as a promising therapy target [17]. The gene discussed is HIF1A; the disease is pancreatic neoplasm.